№ files_lp_3_process_7_090515
File format: docx
Character count: 6757
File size: 41 KB
Year:
2024
Region / City:
Not specified
Topic:
Safety, efficacy, cost-effectiveness of nitrofurantoin in pregnancy
Document Type:
Research article
Organization / Institution:
Journal of Advances in Medicine and Medical Research
Author:
DR (Created by), PM (Checked by), MBM (Approved by)
Target Audience:
Scientific community, healthcare professionals
Period of validity:
Not specified
Approval Date:
07-07-2024
Date of Changes:
Not specified
Ethical Issues:
Not specified
Keywords:
Nitrofurantoin, pregnancy, urinary tract infections, cost-effectiveness, safety, efficacy
Language:
English
Sample Size:
180 participants
Study Design:
Single-center study
Limitations:
Single-center design, no control group, lack of G6PD screening, small sample size, no long-term follow-up of neonatal outcomes
Contextual Description:
Research article exploring the safety, efficacy, and cost-effectiveness of nitrofurantoin for urinary tract infections in pregnancy, highlighting various study limitations and areas for future research.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2024
Region / City:
Wales
Topic:
Healthcare, Pharmacy, Urinary Tract Infection
Document Type:
Patient Group Directions (PGD)
Organisation:
Welsh Medicines Advice Service, NHS Wales
Author:
Dianne Burnett, Louise Allen, Emlyn Pritchard, Adam Mackridge, Richard Coulthard
Target Audience:
Healthcare professionals, community pharmacists
Validity Period:
From 03 June 2024 to 02 June 2027
Approval Date:
22 April 2024
Ratification Date:
09 May 2024
Review Date:
08 February 2027
Expiry Date:
02 June 2027
Version:
1.0
Change History:
Version 1.0 developed on 22 December 2023
Clinical Condition:
Acute, uncomplicated lower urinary tract infection
Treatment:
Nitrofurantoin, Trimethoprim
Applicable Group:
Non-pregnant females or transgender males (16-64 years)
Authorising Organisation:
Local Health Board
Staff Requirements:
Registered pharmacists, authorised by name
Retention Period:
8 years for adults, 25 years for children
Local Inquiries:
[insert local details]
Version:
2.0
Year:
2025
Region / city:
[location/service/organisation]
Topic:
Urinary Tract Infection, Nitrofurantoin, PGD (Patient Group Direction)
Document type:
PGD (Patient Group Direction)
Organization:
UKHSA
Author:
Dr. Diane Ashiru-Oredope, Dr. Imran Jawaid, Dr. Kiren Collison, Dr. Naomi Fleming, Mandy Slatter, Jo Jenkins, Kieran Reynolds, Liz Cross, Professor Bhaskar Somani, Temitope Odetunde, Tracy Rogers
Target audience:
Registered healthcare professionals authorized by their organization
Effective date:
1st January 2026
Review date:
30th June 2028
Expiry date:
31st December 2028
Approval body:
UKHSA HCAI & AMR Division
Document version history:
1.0 (January 2023), 1.1 (July 2023), 1.2 (February 2024), 1.3 (April 2024), 1.4 (January 2025), 2.0 (October 2025)
PGD reviewed by:
National UTI antimicrobial PGD Short Life Working Group
Context:
This document outlines a Patient Group Direction for the use of nitrofurantoin in the treatment of urinary tract infections, specifying authorized practitioners and legal requirements.
Year:
2021
Region / city:
England, Wales
Theme:
Cost-effectiveness, medical imaging, coronary artery disease
Document type:
Research study
Organization / institution:
National Health Service (NHS)
Author:
Not specified
Target audience:
Healthcare professionals, researchers, policymakers
Period of validity:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Year:
2021
Region / City:
Australia
Topic:
Smoking cessation, medicines cost-effectiveness, Pharmaceutical Benefits Scheme
Document type:
Report
Organization:
Pharmaceutical Benefits Advisory Committee
Author:
Centre for Health Economics, Monash University
Target audience:
Health professionals, policy makers, Pharmaceutical Benefits Advisory Committee members
Period of validity:
Not specified
Approval date:
Not specified
Date of amendments:
Not specified
Purpose:
Post-market review, cost-effectiveness evaluation
Clinical issue:
Smoking cessation treatment
Proposed changes to PBS restrictions:
Yes
Market size:
Pharmacological assisted quit attempts
Treatment costs and co-payments:
Yes
Market growth:
Change in quit attempts
Health outcomes:
Quit rates, relapse rates, smoking-related diseases
References:
Yes
Note:
Contextual description
Year:
2023
Region / city:
Australia
Subject:
Pharmaceutical treatment for primary biliary cholangitis
Document type:
Authority submission for PBS listing
Organization:
Emerge Health Pty Ltd
Author:
Emerge Health Pty Ltd
Target audience:
Healthcare professionals, gastroenterologists, hepatologists, prescribers
Period of validity:
Ongoing
Approval date:
Not specified
Date of changes:
Not specified
Year:
2025
Region / City:
United States, California
Topic:
Energy efficiency, Heat pump systems, Cost-effectiveness analysis
Document type:
Research study
Organization:
Pacific Gas and Electric Company, Frontier Energy Inc.
Author:
Kelly Cunningham, Misti Bruceri & Associates, LLC
Target Audience:
Energy program administrators, policymakers, building professionals
Period of validity:
2025
Approval Date:
2025/08/08
Modification Date:
2025/08/08
Year:
2021
Region / City:
Southeast Asia
Topic:
Cost-effectiveness analysis of non-communicable disease prevention strategies
Document Type:
Research Supplementary Material
Organization:
Various health institutions in Southeast Asia
Author:
Thi-Phuong-Lan Nguyen, M. Rifqi Rokhman, Imre Stiensma, Rachmadianti Sukma Hanifa, Due Ong The, Maarten J. Postma, Jurjen van der Schans
Target Audience:
Health policy makers, researchers in public health
Period of Effect:
Not specified
Approval Date:
Not provided
Date of Changes:
Not provided
Context:
The document provides a cost-effectiveness analysis of different prevention strategies for cardiovascular diseases in Southeast Asia.
Year:
2023
Region / City:
United States
Topic:
Health Economics, Neonatal Care
Document Type:
Supplemental Material / Research Table and Figure
Institution:
Academic Medical Center / Research Group
Authors:
Not specified
Target Audience:
Health economists, neonatologists, researchers
Analysis Period:
Short-term (hospital stay) and long-term (childhood)
Data Currency:
US Dollars
Health Conditions Covered:
Intestinal failure-associated liver disease (IFALD), necrotizing enterocolitis, sepsis
Outcomes Measured:
Hospital costs, long-term disability, chronic liver disease, QALY
Methodology:
Cost-effectiveness analysis, transition probabilities, incremental cost-effectiveness ratio (ICER)
Model Population:
Surgical neonates at risk of IFALD and related complications
Year:
2023
Region / City:
Akosombo, Eastern Region, Ghana
Type of Document:
Original Research Article
Institution:
Aquaculture Research and Development Centre (ARDEC), Water Research Institute (WRI), Council for Scientific and Industrial Research (CSIR)
Species Studied:
Nile tilapia (Oreochromis niloticus), African catfish (Clarias gariepinus)
Experimental Duration:
77 days
Feed Types:
Commercial tilapia feed, commercial catfish feed, 1:1 mixture
Key Variables:
Growth performance, cost-effectiveness, profit index
Methodology:
Hapa-in-pond system, manual feeding 3 times daily
Target Audience:
Fish farmers, aquaculture researchers
Experimental Design:
Three treatments (A: tilapia feed, B: catfish feed, C: feed mixture)
Start Date:
July 2023
End Date:
September 2023
Context:
Peer-reviewed aquaculture study evaluating the growth and economic efficiency of mixed-species fingerling rearing using different commercial feed strategies in a pond-based experimental system.
Year:
2021
Region:
California, United States
Document Type:
Regulatory resolution
Institution:
California Public Utilities Commission – Energy Division
Resolution Number:
E-5150
Adoption Date:
June 24, 2021
Subject:
Updates to the Avoided Cost Calculator for distributed energy resource cost-effectiveness analysis
Policy Context:
Distributed Energy Resource (DER) policy and regulatory cost-effectiveness framework
Related Decisions:
D.16-06-007; D.19-05-019; D.20-04-010
Referenced Proceedings:
Integrated Distributed Energy Resources Rulemaking (R.14-10-003); Integrated Resource Planning (R.16-02-007); Distributed Resource Planning (R.14-08-013)
Key Analytical Tool:
Avoided Cost Calculator (ACC)
Update Type:
Minor data updates and modeling adjustments
Primary Data Sources Mentioned:
California Energy Commission Integrated Energy Policy Report (IEPR); IRP modeling outputs; Lazard Levelized Cost of Storage Study 5.0
Stakeholder Process:
Energy Division workshop and stakeholder comments in 2020
Estimated Cost Impact:
No incremental cost
Policy Area:
Energy regulation and distributed energy resources
Year:
2015
Region / City:
London, UK
Theme:
Health Economics, Physical Activity Interventions
Document Type:
Research Article
Author:
N Anokye, J Fox-Rushby, S Sanghera, D G Cook, S M Kerry, E Limb, C R Victor, S Iliffe, S M Shah, M Ussher, P H Whincup, U Ekelund, C Furness, J Ibison, S DeWilde, L David, E Howard, R Dale, J Smith, T J Harris
Target Audience:
Health researchers, policymakers, healthcare professionals
Period of Effectiveness:
2012–2014
Approval Date:
2015
Modification Date:
Not specified
Funding:
National Institute for Health Research Health Technology Assessment Programme (project number HTA 10/32/02 ISRCTN42122561)
Ethics Approval:
London Research Ethics Committee (Hampstead)
Trial Registration:
ISRCTN98538934
Year:
2010–2011
Region:
United Kingdom, England
Subject:
Telehealth, Chronic Obstructive Pulmonary Disease (COPD), Health Economics
Document type:
Research Study / Pilot Programme Report
Organization:
National Health Service Direct (NHSD)
Authors:
Not specified
Target population:
Patients with chronic obstructive pulmonary disease (COPD)
Study sites:
Two Primary Care Trusts (PCT1, PCT2)
Participants:
321 enrolled, 227 included in final analysis
Intervention:
Remote patient monitoring / telehealth
Outcome measures:
Cost-effectiveness, resource utilization, hospital admissions, length of stay
Data collection period:
12 months before, immediately before, and during monitoring
Keywords:
telehealth, telemedicine, cost-effectiveness, remote patient monitoring
Year:
2025
Region / city:
Victoria, Australia
Topic:
Health, Urinary Tract Infection, Pharmacist Services
Document type:
Patient handout
Author:
Department of Health, Victoria Government
Target audience:
Women and gender diverse people with female biology aged 18-65, including Medicare and international students
Period of validity:
December 2025
Approval date:
December 2025
Date of updates:
Not specified
Year:
2023
Region / City:
New Zealand
Subject:
Medical referral for Stress Urinary Incontinence (SUI) treatment
Document Type:
Medical Referral Form
Institution:
Manatū Hauora (Health Ministry)
Author:
Not specified
Target Audience:
Healthcare professionals (Referring clinicians, specialists)
Period of Application:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Description:
Form for referring patients with stress urinary incontinence for multidisciplinary discussion and evaluation, including medical history, symptoms, diagnostic tests, and treatment options.
Year:
2024
Region / City:
Wales
Topic:
Healthcare, Pharmacy, Urinary Tract Infection
Document Type:
Patient Group Directions (PGD)
Organisation:
Welsh Medicines Advice Service, NHS Wales
Author:
Dianne Burnett, Louise Allen, Emlyn Pritchard, Adam Mackridge, Richard Coulthard
Target Audience:
Healthcare professionals, community pharmacists
Validity Period:
From 03 June 2024 to 02 June 2027
Approval Date:
22 April 2024
Ratification Date:
09 May 2024
Review Date:
08 February 2027
Expiry Date:
02 June 2027
Version:
1.0
Change History:
Version 1.0 developed on 22 December 2023
Clinical Condition:
Acute, uncomplicated lower urinary tract infection
Treatment:
Nitrofurantoin, Trimethoprim
Applicable Group:
Non-pregnant females or transgender males (16-64 years)
Authorising Organisation:
Local Health Board
Staff Requirements:
Registered pharmacists, authorised by name
Retention Period:
8 years for adults, 25 years for children
Local Inquiries:
[insert local details]
Year:
2024
Region / city:
Victoria, Australia
Topic:
Urinary Tract Infection Treatment
Document Type:
Patient Handout
Organ / Institution:
Department of Health, Victoria
Author:
Department of Health, Victoria
Target Audience:
Women and gender diverse people with female biology aged 18-65
Period of validity:
March 2024
Approval date:
March 2024
Date of amendments:
N/A
Contextual Description:
Patient handout providing details about treatment, eligibility, and self-care for uncomplicated urinary tract infection under a pilot program for community pharmacists.
Note:
Year
Subject:
Healthcare Plan, Risk Management
Document Type:
Healthcare Plan
Target Audience:
Individuals at risk of urinary tract infections
Year:
2023
Region / City:
Canberra
Topic:
Healthcare Procedure
Document Type:
Procedure Manual
Organization:
Canberra Health Services
Author:
Not specified
Target Audience:
Healthcare professionals (nurses, doctors, allied health staff)
Period of validity:
Ongoing
Approval Date:
Not specified
Date of Amendments:
Not specified
Year:
2022
Region / city:
United Kingdom
Topic:
Healthcare, Infectious Diseases, Antimicrobial Resistance
Document Type:
Briefing Paper
Organization / Institution:
National Institute for Health and Care Excellence
Author:
NICE
Target Audience:
Healthcare professionals, Policy makers, Researchers
Period of validity:
Not specified
Approval Date:
12th July 2022
Date of Changes:
Not specified
Year:
2022
Region / city:
United Kingdom
Subject:
Health care, Medical guidelines
Document type:
Quality standard
Organization / institution:
National Institute for Health and Care Excellence (NICE)
Author:
National Institute for Health and Care Excellence (NICE)
Target audience:
Healthcare professionals, Service providers
Period of validity:
2022-2023
Approval date:
11 June 2015
Date of amendments:
6 September 2022
Note:
Contextual description